Precision Diabetes

Precision Diabetes is an emerging leader in achieving precision medicine for diabetes through the use of novel diabetes biomarkers and algorithms. The company's mission is to revolutionize the diagnostic evaluation of diabetes by providing a unique range of diabetes tests, from the risk of developing diabetes to the development of diabetes complications. The Precision Diabetes product portfolio includes several novel diabetes biomarkers and is the exclusive supplier of the GlycoMark test in the United States, Europe, Australia, Asia-Pacific, the Middle East, and Mexico. Precision Diabetes also collaborates with Patia Europe to distribute new genetic tests for type 2 diabetes, DIABETESpredict, and gestational diabetes genetic test Matergen, in the United States.